BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22228213)

  • 1. SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis.
    Pass C; MacRae VE; Huesa C; Faisal Ahmed S; Farquharson C
    J Bone Miner Res; 2012 May; 27(5):1055-66. PubMed ID: 22228213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor-kappaB (NF-kappaB) p65 interacts with Stat5b in growth plate chondrocytes and mediates the effects of growth hormone on chondrogenesis and on the expression of insulin-like growth factor-1 and bone morphogenetic protein-2.
    Wu S; Morrison A; Sun H; De Luca F
    J Biol Chem; 2011 Jul; 286(28):24726-34. PubMed ID: 21592969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct stimulation of bone mass by increased GH signalling in the osteoblasts of Socs2-/- mice.
    Dobie R; MacRae VE; Huesa C; van't Hof R; Ahmed SF; Farquharson C
    J Endocrinol; 2014 Oct; 223(1):93-106. PubMed ID: 25074853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased bone mass, altered trabecular architecture and modified growth plate organization in the growing skeleton of SOCS2 deficient mice.
    Macrae VE; Horvat S; Pells SC; Dale H; Collinson RS; Pitsillides AA; Ahmed SF; Farquharson C
    J Cell Physiol; 2009 Feb; 218(2):276-84. PubMed ID: 18803233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased linear bone growth by GH in the absence of SOCS2 is independent of IGF-1.
    Dobie R; Ahmed SF; Staines KA; Pass C; Jasim S; MacRae VE; Farquharson C
    J Cell Physiol; 2015 Nov; 230(11):2796-806. PubMed ID: 25833299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-Like Growth Factor-Independent Effects of Growth Hormone on Growth Plate Chondrogenesis and Longitudinal Bone Growth.
    Wu S; Yang W; De Luca F
    Endocrinology; 2015 Jul; 156(7):2541-51. PubMed ID: 25910049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-I and fibroblast growth factor, but not growth hormone, affect growth plate chondrocyte proliferation.
    Hutchison MR; Bassett MH; White PC
    Endocrinology; 2007 Jul; 148(7):3122-30. PubMed ID: 17395707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte.
    Yang HL; Sun C; Sun C; Qi RL
    Mol Biol Rep; 2012 Sep; 39(9):9113-22. PubMed ID: 22729878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate.
    Wu S; Levenson A; Kharitonenkov A; De Luca F
    J Biol Chem; 2012 Jul; 287(31):26060-7. PubMed ID: 22696219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
    Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
    Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramide inhibition of chondrocyte proliferation and bone growth is IGF-I independent.
    MacRae VE; Burdon T; Ahmed SF; Farquharson C
    J Endocrinol; 2006 Nov; 191(2):369-77. PubMed ID: 17088406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of cytokine signaling 2 (
    Dobie R; MacRae VE; Pass C; Milne EM; Ahmed SF; Farquharson C
    Dis Model Mech; 2018 Jan; 11(1):. PubMed ID: 29343614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and linear bone growth: the inhibitory role of SOCS2 on GH/IGF-1 signaling.
    Farquharson C; Ahmed SF
    Pediatr Nephrol; 2013 Apr; 28(4):547-56. PubMed ID: 22886280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis.
    de Andrés MC; Imagawa K; Hashimoto K; Gonzalez A; Goldring MB; Roach HI; Oreffo RO
    Biochem Biophys Res Commun; 2011 Apr; 407(1):54-9. PubMed ID: 21352802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal Transduction for TNFα-Induced Type II SOCS Expression and Its Functional Implication in Growth Hormone Resistance in Carp Hepatocytes.
    Jiang X; He M; Bai J; Chan CB; Wong AOL
    Front Endocrinol (Lausanne); 2020; 11():20. PubMed ID: 32082258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway.
    Sahni M; Ambrosetti DC; Mansukhani A; Gertner R; Levy D; Basilico C
    Genes Dev; 1999 Jun; 13(11):1361-6. PubMed ID: 10364154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the proteasomal function in chondrocytes down-regulates growth plate chondrogenesis and longitudinal bone growth.
    Wu S; De Luca F
    Endocrinology; 2006 Aug; 147(8):3761-8. PubMed ID: 16675523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epiphyseal growth plate growth hormone receptor signaling is decreased in chronic kidney disease-related growth retardation.
    Troib A; Landau D; Kachko L; Rabkin R; Segev Y
    Kidney Int; 2013 Nov; 84(5):940-9. PubMed ID: 23715123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo.
    Michaylira CZ; Simmons JG; Ramocki NM; Scull BP; McNaughton KK; Fuller CR; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G472-81. PubMed ID: 16574995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.